Transgene Biotek Profit & Loss Annual

Trade
BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs
6.44 -0.01 (-0.16%)Updated : 21 May 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 0.060.090.170.00
Total Revenue 0.060.090.170.00
Costof Revenue Total 0.07-0.050.060.01
Gross Profit -0.010.130.11-0.01
Selling/ General/ Admin Expenses Total 0.300.290.250.29
Depreciation/ Amortization 4.959.929.919.90
Other Operating Expenses Total 0.740.310.390.56
Total Operating Expense 6.0610.4710.6010.76
Operating Income -6.00-10.39-10.44-10.76
Interest Inc( Exp) Net- Non- Op Total -1.81-2.27-2.66-3.81
Gain( Loss)on Saleof Assets 0.000.000.000.00
Other Net 0.180.210.270.18
Net Income Before Taxes -6.01-10.40-10.43-10.96
Provisionfor Income Taxes 0.000.00--
Net Income After Taxes -6.01-10.40-10.43-10.96
Net Income Before Extra Items -6.01-10.40-10.43-10.96
Net Income -6.01-10.40-10.43-10.96
Income Availableto Com Excl Extra Ord -6.01-10.40-10.43-10.96
Income Availableto Com Incl Extra Ord -6.01-10.40-10.43-10.96
Diluted Net Income -6.01-10.40-10.43-10.96
Diluted Weighted Average Shares 7.587.587.587.58
Diluted EPS Excluding Extra Ord Items -0.79-1.37-1.38-1.45
Diluted Normalized EPS -0.79-1.37-1.38-1.45
*All figures in crores except per share values
Recommended For You
Trending Stocks
174.30+6.40(3.81%)
1,327.00+21.50(1.65%)
2,467.95-34.25 (-1.37%)
12,473.85-129.50 (-1.03%)
HomeMarketsPremiumFor youGet App